GNC Rips Plaintiff Studies In Bid To Kill Supplement MDL

Law360, Los Angeles (May 12, 2014, 3:40 PM EDT) -- GNC Corp. on Friday urged a federal judge to toss multidistrict litigation alleging the company falsely claimed its TriFlex dietary supplement improved joint mobility and regenerated cartilage, saying the plaintiffs offered irrelevant clinical studies to support their case and may not have used the supplement properly.

"Indeed, the plaintiffs here — who claim to be representative of and pursuing claims typical to the rest of the class — purchased minimal amounts of the product, often only a single bottle, and they have not identified any facts...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.